0001959576-26-000001.txt : 20260819 0001959576-26-000001.hdr.sgml : 20260819 20260819132619 ACCESSION NUMBER: 0001959576-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260819 DATE AS OF CHANGE: 20260819 EFFECTIVENESS DATE: 20260819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aer Therapeutics, Inc. CENTRAL INDEX KEY: 0001959576 ORGANIZATION NAME: EIN: 465377414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-594730 FILM NUMBER: 261294485 BUSINESS ADDRESS: STREET 1: 14460 FALLS OF NEUSE RD STREET 2: SUITE 149342 CITY: RALEIGH STATE: NC ZIP: 27614 BUSINESS PHONE: 919-345-4256 MAIL ADDRESS: STREET 1: 14460 FALLS OF NEUSE RD STREET 2: SUITE 149342 CITY: RALEIGH STATE: NC ZIP: 27614 D 1 primary_doc.xml X0708 D LIVE 0001959576 Aer Therapeutics, Inc. 8 Davis Dr Research Triangle Park NC NORTH CAROLINA 27709 213-247-8328 DELAWARE None None Corporation true Thomas Mathers 8 Davis Dr Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director John Fahy 8 Davis Dr Research Triangle Park NC NORTH CAROLINA 27709 Director Evan Caplan 8 Davis Dr Research Triangle Park NC NORTH CAROLINA 27709 Director Tim Shannon 8 Davis Dr Research Triangle Park NC NORTH CAROLINA 27709 Director Christy Shaffer 8 Davis Dr Research Triangle Park NC NORTH CAROLINA 27709 Director Biotechnology Decline to Disclose 06b false 2026-08-07 false true true true false 0 3000000 3000000 0 false 7 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Aer Therapeutics, Inc. Thomas Mathers Thomas Mathers Chairman of the Board of Directors 2026-08-18